With a weight-loss pill on the horizon and the FDA’s signal of a tougher stance on compounded knockoffs, Novo Nordisk might ...

Wall Street finished the week on a strong note as all three major market averages tagged record levels on Friday. For the ...

Online pharmacies are using a loophole to continue selling cheap weight loss drugs that are modeled on Ozempic and Mounjaro, ...

Novo Nordisk said participants who took the once-daily pill in a clinical trial lost an average 16% of their body weight.

Patients on daily pill lost about 17% of body weight in trial Results nearly identical to injectable Wegovy New obesity pill ...

A Novo Nordisk-designed trial, conducted at 68 international hospitals, specialist clinics, and medical centers with ...

Novo Nordisk has a strong financial position and portfolio of weight-loss and diabetes treatments. See why NVO’s stock dip ...

The FDA's warnings to Eli Lilly, Novo Nordisk and Hims & Hers spotlight risks for ETFs tied to the weight-loss drug boom.

"That's an easy move to make out of the gate, but it's also unusual at Novo, and it's piqued investor interest," said ...

Federal health officials are cracking down on telehealth companies' promotion of unapproved versions of prescription drugs, ...

For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions of ...